Ocular Therapeutix, Inc.OCULNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank15
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-8.55
↑ 31% vs avg
Percentile
P15
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-12.37
Historical baseline
PeriodValueYoY Change
2025-8.55-22.4%
2024-6.98-58.4%
2023-4.41-45.0%
2022-3.04+96.3%
2021-81.25-905.6%
2020-8.08-290.3%
2019-2.07+21.3%
2018-2.63-30.0%
2017-2.02+56.5%
2016-4.65-